AXIM BIOTECHNOLOGIES, INC. (AXIM) Free cash flow 2014–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.0MFY2023 · since FY2014: -$338,999 → -$1.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$1.0M | +49.8% |
| FY2022 | -$2.1M | +18.8% |
| FY2021 | -$2.5M | +23.7% |
| FY2020 | -$3.3M | — |
| FY2016 | -$1.3M | +16.8% |
| FY2015 | -$1.6M | -359.0% |
| FY2014 | -$338,999 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AXIM financial trends
AXIM RevenueAXIM Net incomeAXIM Net marginAXIM Gross profitAXIM Gross marginAXIM Operating incomeAXIM Operating marginAXIM Operating cash flowAXIM Capital expendituresAXIM Return on equityAXIM Stock buybacksAXIM Dividends paidAXIM Total assetsAXIM Total liabilitiesAXIM Shareholders’ equityAXIM overview →